捷絡生技3D+AI判讀2023上半年攻FDA醫財證
原文連結>>>
媒體報導
Intel、Roche與捷絡生技JelloX攜手成立『數位病理產業聯盟』，推動次世代數位病理平台於醫療場景的應用
捷絡生技在2022醫療科技展與英特爾(Intel)、台灣羅氏診斷(Roche Diagnostic)宣布成立數 …
Intel、Roche與捷絡生技JelloX攜手成立『數位病理產業聯盟』，推動次世代數位病理平台於醫療場景的應用 閱讀全文 »
推動醫健資料跨域串聯！經濟部、資策會攜14醫照機構、5業者簽約建構『生醫健康資料商化應用平台』
捷絡生技參與經濟部技術處與資策會推動醫療健康資料跨域串聯，鏈結法人與醫院系統建構「生醫健康資料商化應用平台」， …
JelloX Biotech Leads Research in 3D Cancer Pathology as NCI Explores Potential
捷絡生技3D數位病理影像暨AI輔助診斷已成功應用於肺癌、前列腺癌、口腔癌病灶型態與分子標靶分析，並可整合傳統分 …
JelloX Biotech Leads Research in 3D Cancer Pathology as NCI Explores Potential 閱讀全文 »
JelloX Biotech helps doctors diagnose and treat cancer tumors with speed and accuracy
Taiwan-based start-up, JelloX Biotech, says its product …
JelloX Biotech helps doctors diagnose and treat cancer tumors with speed and accuracy 閱讀全文 »
Rise of next-generation biotech CEOs in Taiwan
The 1st 2022 Best Bio Startup CEO Award announced winne …